Shukra Pharmaceuticals Limited reported earnings results for the full year ended March 31, 2022. For the full year, the company reported sales was INR 204.86 million compared to INR 111.96 million a year ago. Revenue was INR 205.67 million compared to INR 115.52 million a year ago. Net income was INR 7.51 million compared to INR 0.339 million a year ago. Basic earnings per share from continuing operations was INR 4.79 compared to INR 0.22 a year ago. Diluted earnings per share from continuing operations was INR 4.79 compared to INR 0.22 a year ago.